Abstract
TUMOUR cells, both animal and human, are actively motile in tissue culture1,2. Simple techniques have recently become available for the quantitation of this motility3,4, and Friberg et al.3 have shown that the motility of mouse lymphoma cells can be inhibited by a concentration of concanavalin A below that which causes agglutination.
This is a preview of subscription content, access via your institution
Access options
References
Lambert, R. A., J. Cancer Res., 1, 169 (1916).
Enterline, H. T., and Coman, D. R., Cancer, 3, 1033 (1950).
Friberg, S., Cochran, A. J., and Golub, S. H., Nature, 232, 121 (1971).
Cochran, A. J., Rev. Europ. Etudes Clin. Biol., 16, 44 (1971).
David, J. R., Al-Askari, S., and Lawrence, H. S., Transplantation, 7, 299 (1969).
Dimitriu, A., Soucy, P. E., and Hamburger, J., Transplant Proc., 4, 275 (1972).
Wolf, A., Barfoot, R., and Johnson, R. A., Immunology, 22, 485 (1972).
David, J. R., Fed. Proc., 27, 21 (1968).
Evans, R., and Alexander, P., Transplantation, 12, 227 (1971).
Waldeyer, Virchows Arch. Path. Anat., 55, 67 (1872).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
CURRIE, G., SLME, G. Syngeneic Immune Serum Specifically Inhibits the Motility of Tumour Cells. Nature New Biology 241, 284–285 (1973). https://doi.org/10.1038/newbio241284a0
Received:
Issue date:
DOI: https://doi.org/10.1038/newbio241284a0